Treatment of experimental allergic encephalomyelitis (EAE) by a rationally designed cyclic analogue of myelin basic protein (MBP) epitope 72–85

In this report the rational design, synthesis and pharmacological properties of an amide-linked cyclic antagonist analogue of the guinea pig myelin basic protein epitope MBP 72–85 are described. Design of the potent cyclic analogue was based on 2D NOESY nuclear magnetic resonance and molecular dynam...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2000-12, Vol.10 (24), p.2713-2717
Hauptverfasser: Tselios, Theodore, Daliani, Ioanna, Deraos, Spyros, Thymianou, Soteria, Matsoukas, Elisabeth, Troganis, Anastasios, Gerothanassis, Ioannis, Mouzaki, Athanasia, Mavromoustakos, Thomas, Probert, Lesley, Matsoukas, John
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2717
container_issue 24
container_start_page 2713
container_title Bioorganic & medicinal chemistry letters
container_volume 10
creator Tselios, Theodore
Daliani, Ioanna
Deraos, Spyros
Thymianou, Soteria
Matsoukas, Elisabeth
Troganis, Anastasios
Gerothanassis, Ioannis
Mouzaki, Athanasia
Mavromoustakos, Thomas
Probert, Lesley
Matsoukas, John
description In this report the rational design, synthesis and pharmacological properties of an amide-linked cyclic antagonist analogue of the guinea pig myelin basic protein epitope MBP 72–85 are described. Design of the potent cyclic analogue was based on 2D NOESY nuclear magnetic resonance and molecular dynamics studies carried out in the linear antagonist Ala 81MBP 72–85. The cyclic antagonist completely prevented the induction of experimental allergic/autoimmune encephalomyelitis when coinjected with linear and cyclic agonist analogues MBP 72–85 and cyclo(2–9)MBP 72–85.
doi_str_mv 10.1016/S0960-894X(00)00556-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72523666</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X00005564</els_id><sourcerecordid>72523666</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-c1bb82f9bf9e116dde6d29b88524915fff92aa14a3fb1facb7c3612ef3712f053</originalsourceid><addsrcrecordid>eNqFkd2KFDEQhYMo7rj6CEpAkJmL1ko6SXdfybqMP7Ci4ArehXS6MkYy3b1Jj9h3voL4hj6JmR_WS6-KqnynUpxDyGMGzxkw9eITNAqKuhFflgArAClVIe6QBRNKFKUAeZcsbpEz8iClbwBMgBD3yRljrCyhkgvy6zqimbbYT3RwFH-MGP2-M4GaEDBuvKXYWxy_mjBsZwx-8oku1xfrFW1namg0kx_6zM60w-Q3PXbUzjZkncnjYbPD_eaDtKetSflhjMOEuVu-f_VxRXH00zAirfifn79r-ZDccyYkfHSq5-Tz6_X15dvi6sObd5cXV4Ut62YqLGvbmrumdQ0yproOVcebtq4lFw2TzrmGG8OEKV3LnLFtZUvFOLqyYtyBLM_Js-PefM3NDtOktz5ZDMH0OOySrrjkpVIqg_II2jikFNHpMXtk4qwZ6H0W-pCF3hutAfQhCy2y7snpg127xe6f6mR-Bp6eAJOsCS6a3vp0y9VcVgCZenmkMJvx3WPUyfp9JJ2PaCfdDf4_h_wFAxeoYQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72523666</pqid></control><display><type>article</type><title>Treatment of experimental allergic encephalomyelitis (EAE) by a rationally designed cyclic analogue of myelin basic protein (MBP) epitope 72–85</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Tselios, Theodore ; Daliani, Ioanna ; Deraos, Spyros ; Thymianou, Soteria ; Matsoukas, Elisabeth ; Troganis, Anastasios ; Gerothanassis, Ioannis ; Mouzaki, Athanasia ; Mavromoustakos, Thomas ; Probert, Lesley ; Matsoukas, John</creator><creatorcontrib>Tselios, Theodore ; Daliani, Ioanna ; Deraos, Spyros ; Thymianou, Soteria ; Matsoukas, Elisabeth ; Troganis, Anastasios ; Gerothanassis, Ioannis ; Mouzaki, Athanasia ; Mavromoustakos, Thomas ; Probert, Lesley ; Matsoukas, John</creatorcontrib><description>In this report the rational design, synthesis and pharmacological properties of an amide-linked cyclic antagonist analogue of the guinea pig myelin basic protein epitope MBP 72–85 are described. Design of the potent cyclic analogue was based on 2D NOESY nuclear magnetic resonance and molecular dynamics studies carried out in the linear antagonist Ala 81MBP 72–85. The cyclic antagonist completely prevented the induction of experimental allergic/autoimmune encephalomyelitis when coinjected with linear and cyclic agonist analogues MBP 72–85 and cyclo(2–9)MBP 72–85.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/S0960-894X(00)00556-4</identifier><identifier>PMID: 11133075</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Animals ; Biological and medical sciences ; Drug Design ; Encephalomyelitis, Autoimmune, Experimental - drug therapy ; Encephalomyelitis, Autoimmune, Experimental - pathology ; Encephalomyelitis, Autoimmune, Experimental - prevention &amp; control ; Epitopes - administration &amp; dosage ; Epitopes - pharmacology ; Experimental and animal immunopathology. Animal models ; Guinea Pigs ; Immunization ; Immunopathology ; Medical sciences ; Models, Molecular ; Myelin Basic Protein - chemical synthesis ; Myelin Basic Protein - immunology ; Myelin Basic Protein - pharmacology ; Nuclear Magnetic Resonance, Biomolecular ; Peptide Fragments - chemical synthesis ; Peptide Fragments - immunology ; Peptide Fragments - pharmacology ; Peptides, Cyclic - chemical synthesis ; Peptides, Cyclic - immunology ; Peptides, Cyclic - pharmacology ; Rats ; Rats, Inbred Lew ; Spinal Cord - drug effects ; Spinal Cord - pathology</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2000-12, Vol.10 (24), p.2713-2717</ispartof><rights>2000 Elsevier Science Ltd</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-c1bb82f9bf9e116dde6d29b88524915fff92aa14a3fb1facb7c3612ef3712f053</citedby><cites>FETCH-LOGICAL-c389t-c1bb82f9bf9e116dde6d29b88524915fff92aa14a3fb1facb7c3612ef3712f053</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0960-894X(00)00556-4$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=825700$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11133075$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tselios, Theodore</creatorcontrib><creatorcontrib>Daliani, Ioanna</creatorcontrib><creatorcontrib>Deraos, Spyros</creatorcontrib><creatorcontrib>Thymianou, Soteria</creatorcontrib><creatorcontrib>Matsoukas, Elisabeth</creatorcontrib><creatorcontrib>Troganis, Anastasios</creatorcontrib><creatorcontrib>Gerothanassis, Ioannis</creatorcontrib><creatorcontrib>Mouzaki, Athanasia</creatorcontrib><creatorcontrib>Mavromoustakos, Thomas</creatorcontrib><creatorcontrib>Probert, Lesley</creatorcontrib><creatorcontrib>Matsoukas, John</creatorcontrib><title>Treatment of experimental allergic encephalomyelitis (EAE) by a rationally designed cyclic analogue of myelin basic protein (MBP) epitope 72–85</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>In this report the rational design, synthesis and pharmacological properties of an amide-linked cyclic antagonist analogue of the guinea pig myelin basic protein epitope MBP 72–85 are described. Design of the potent cyclic analogue was based on 2D NOESY nuclear magnetic resonance and molecular dynamics studies carried out in the linear antagonist Ala 81MBP 72–85. The cyclic antagonist completely prevented the induction of experimental allergic/autoimmune encephalomyelitis when coinjected with linear and cyclic agonist analogues MBP 72–85 and cyclo(2–9)MBP 72–85.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Drug Design</subject><subject>Encephalomyelitis, Autoimmune, Experimental - drug therapy</subject><subject>Encephalomyelitis, Autoimmune, Experimental - pathology</subject><subject>Encephalomyelitis, Autoimmune, Experimental - prevention &amp; control</subject><subject>Epitopes - administration &amp; dosage</subject><subject>Epitopes - pharmacology</subject><subject>Experimental and animal immunopathology. Animal models</subject><subject>Guinea Pigs</subject><subject>Immunization</subject><subject>Immunopathology</subject><subject>Medical sciences</subject><subject>Models, Molecular</subject><subject>Myelin Basic Protein - chemical synthesis</subject><subject>Myelin Basic Protein - immunology</subject><subject>Myelin Basic Protein - pharmacology</subject><subject>Nuclear Magnetic Resonance, Biomolecular</subject><subject>Peptide Fragments - chemical synthesis</subject><subject>Peptide Fragments - immunology</subject><subject>Peptide Fragments - pharmacology</subject><subject>Peptides, Cyclic - chemical synthesis</subject><subject>Peptides, Cyclic - immunology</subject><subject>Peptides, Cyclic - pharmacology</subject><subject>Rats</subject><subject>Rats, Inbred Lew</subject><subject>Spinal Cord - drug effects</subject><subject>Spinal Cord - pathology</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkd2KFDEQhYMo7rj6CEpAkJmL1ko6SXdfybqMP7Ci4ArehXS6MkYy3b1Jj9h3voL4hj6JmR_WS6-KqnynUpxDyGMGzxkw9eITNAqKuhFflgArAClVIe6QBRNKFKUAeZcsbpEz8iClbwBMgBD3yRljrCyhkgvy6zqimbbYT3RwFH-MGP2-M4GaEDBuvKXYWxy_mjBsZwx-8oku1xfrFW1namg0kx_6zM60w-Q3PXbUzjZkncnjYbPD_eaDtKetSflhjMOEuVu-f_VxRXH00zAirfifn79r-ZDccyYkfHSq5-Tz6_X15dvi6sObd5cXV4Ut62YqLGvbmrumdQ0yproOVcebtq4lFw2TzrmGG8OEKV3LnLFtZUvFOLqyYtyBLM_Js-PefM3NDtOktz5ZDMH0OOySrrjkpVIqg_II2jikFNHpMXtk4qwZ6H0W-pCF3hutAfQhCy2y7snpg127xe6f6mR-Bp6eAJOsCS6a3vp0y9VcVgCZenmkMJvx3WPUyfp9JJ2PaCfdDf4_h_wFAxeoYQ</recordid><startdate>20001218</startdate><enddate>20001218</enddate><creator>Tselios, Theodore</creator><creator>Daliani, Ioanna</creator><creator>Deraos, Spyros</creator><creator>Thymianou, Soteria</creator><creator>Matsoukas, Elisabeth</creator><creator>Troganis, Anastasios</creator><creator>Gerothanassis, Ioannis</creator><creator>Mouzaki, Athanasia</creator><creator>Mavromoustakos, Thomas</creator><creator>Probert, Lesley</creator><creator>Matsoukas, John</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20001218</creationdate><title>Treatment of experimental allergic encephalomyelitis (EAE) by a rationally designed cyclic analogue of myelin basic protein (MBP) epitope 72–85</title><author>Tselios, Theodore ; Daliani, Ioanna ; Deraos, Spyros ; Thymianou, Soteria ; Matsoukas, Elisabeth ; Troganis, Anastasios ; Gerothanassis, Ioannis ; Mouzaki, Athanasia ; Mavromoustakos, Thomas ; Probert, Lesley ; Matsoukas, John</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-c1bb82f9bf9e116dde6d29b88524915fff92aa14a3fb1facb7c3612ef3712f053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Drug Design</topic><topic>Encephalomyelitis, Autoimmune, Experimental - drug therapy</topic><topic>Encephalomyelitis, Autoimmune, Experimental - pathology</topic><topic>Encephalomyelitis, Autoimmune, Experimental - prevention &amp; control</topic><topic>Epitopes - administration &amp; dosage</topic><topic>Epitopes - pharmacology</topic><topic>Experimental and animal immunopathology. Animal models</topic><topic>Guinea Pigs</topic><topic>Immunization</topic><topic>Immunopathology</topic><topic>Medical sciences</topic><topic>Models, Molecular</topic><topic>Myelin Basic Protein - chemical synthesis</topic><topic>Myelin Basic Protein - immunology</topic><topic>Myelin Basic Protein - pharmacology</topic><topic>Nuclear Magnetic Resonance, Biomolecular</topic><topic>Peptide Fragments - chemical synthesis</topic><topic>Peptide Fragments - immunology</topic><topic>Peptide Fragments - pharmacology</topic><topic>Peptides, Cyclic - chemical synthesis</topic><topic>Peptides, Cyclic - immunology</topic><topic>Peptides, Cyclic - pharmacology</topic><topic>Rats</topic><topic>Rats, Inbred Lew</topic><topic>Spinal Cord - drug effects</topic><topic>Spinal Cord - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tselios, Theodore</creatorcontrib><creatorcontrib>Daliani, Ioanna</creatorcontrib><creatorcontrib>Deraos, Spyros</creatorcontrib><creatorcontrib>Thymianou, Soteria</creatorcontrib><creatorcontrib>Matsoukas, Elisabeth</creatorcontrib><creatorcontrib>Troganis, Anastasios</creatorcontrib><creatorcontrib>Gerothanassis, Ioannis</creatorcontrib><creatorcontrib>Mouzaki, Athanasia</creatorcontrib><creatorcontrib>Mavromoustakos, Thomas</creatorcontrib><creatorcontrib>Probert, Lesley</creatorcontrib><creatorcontrib>Matsoukas, John</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tselios, Theodore</au><au>Daliani, Ioanna</au><au>Deraos, Spyros</au><au>Thymianou, Soteria</au><au>Matsoukas, Elisabeth</au><au>Troganis, Anastasios</au><au>Gerothanassis, Ioannis</au><au>Mouzaki, Athanasia</au><au>Mavromoustakos, Thomas</au><au>Probert, Lesley</au><au>Matsoukas, John</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of experimental allergic encephalomyelitis (EAE) by a rationally designed cyclic analogue of myelin basic protein (MBP) epitope 72–85</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2000-12-18</date><risdate>2000</risdate><volume>10</volume><issue>24</issue><spage>2713</spage><epage>2717</epage><pages>2713-2717</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>In this report the rational design, synthesis and pharmacological properties of an amide-linked cyclic antagonist analogue of the guinea pig myelin basic protein epitope MBP 72–85 are described. Design of the potent cyclic analogue was based on 2D NOESY nuclear magnetic resonance and molecular dynamics studies carried out in the linear antagonist Ala 81MBP 72–85. The cyclic antagonist completely prevented the induction of experimental allergic/autoimmune encephalomyelitis when coinjected with linear and cyclic agonist analogues MBP 72–85 and cyclo(2–9)MBP 72–85.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>11133075</pmid><doi>10.1016/S0960-894X(00)00556-4</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2000-12, Vol.10 (24), p.2713-2717
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_72523666
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Animals
Biological and medical sciences
Drug Design
Encephalomyelitis, Autoimmune, Experimental - drug therapy
Encephalomyelitis, Autoimmune, Experimental - pathology
Encephalomyelitis, Autoimmune, Experimental - prevention & control
Epitopes - administration & dosage
Epitopes - pharmacology
Experimental and animal immunopathology. Animal models
Guinea Pigs
Immunization
Immunopathology
Medical sciences
Models, Molecular
Myelin Basic Protein - chemical synthesis
Myelin Basic Protein - immunology
Myelin Basic Protein - pharmacology
Nuclear Magnetic Resonance, Biomolecular
Peptide Fragments - chemical synthesis
Peptide Fragments - immunology
Peptide Fragments - pharmacology
Peptides, Cyclic - chemical synthesis
Peptides, Cyclic - immunology
Peptides, Cyclic - pharmacology
Rats
Rats, Inbred Lew
Spinal Cord - drug effects
Spinal Cord - pathology
title Treatment of experimental allergic encephalomyelitis (EAE) by a rationally designed cyclic analogue of myelin basic protein (MBP) epitope 72–85
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T02%3A40%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20experimental%20allergic%20encephalomyelitis%20(EAE)%20by%20a%20rationally%20designed%20cyclic%20analogue%20of%20myelin%20basic%20protein%20(MBP)%20epitope%2072%E2%80%9385&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Tselios,%20Theodore&rft.date=2000-12-18&rft.volume=10&rft.issue=24&rft.spage=2713&rft.epage=2717&rft.pages=2713-2717&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/S0960-894X(00)00556-4&rft_dat=%3Cproquest_cross%3E72523666%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72523666&rft_id=info:pmid/11133075&rft_els_id=S0960894X00005564&rfr_iscdi=true